The stock of Teladoc Health Inc. (NYSE:TDOC) increased by $0.05 on Monday to $22.09, up 0.23 percent. The last five days have seen an average of 3,363,304 shares of common stock traded. 8 times new highs were reached in the current year, with a fall of -$1.58. The average number of shares traded over the last 20 days was 4,360,626, while the average volume over the last 50 days totaled 5,804,712.
TDOC stock dropped -21.83% since last month. On 08/25/23, the company’s shares reached a one-month low of $21.21. The stock touched a high of $34.75 on 02/02/23, after rallying from a low of $21.21 in 52 weeks. The price of TDOC stock has declined by -6.60% or -$1.58 this year, reaching a new high 8 times. Still, the stock price is down -36.43% from the 52-week high.
Insider Transactions
TDOC stock investors should be aware that Teladoc Health Inc. (TDOC) stock had its last reported insider trading activity 11 days ago on Aug 17. On Aug 17, CHIEF STRATEGY OFFICER Trencher Daniel sold 1,000 shares at $22.81 each. This transaction resulted in the insider making $22,810. On Aug 02, Waters Michael Willem sold 19,340 shares at a price of US$27.03. After the transaction, the insider now owns 25,937 shares. CHIEF MEDICAL OFFICER Raman-Tangella Vidya had earlier sold 5,215 shares on Aug 02 for $27.03 a share. The transaction was completed for $140,956.
Valuation Metrics
Beta for the stock is 1.13. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.43, the price-to-book (PB) ratio of 1.58, and the price-to-cash flow ratio of 57.03.
Financial Health
For the three months ended June 29, Teladoc Health Inc.’s quick ratio was 3.40, while its current ratio was 3.40, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.67, and the total debt to equity ratio is 0.67. As far as profitability goes, gross margin for the trailing twelve months is 70.20% percent. Based on annual data, it had gross profit of $1.66 billion and revenue of $2.41 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. TDOC’s return on assets (ROA) during the last 12 months has been -76.30%. There was a -353.40% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -124.10%.
Earnings Surprise
According to Teladoc Health Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $652.41 million, while revenues rose by 9.2% to $629.24 million. It was predicted that Teladoc Health Inc.’s quarterly earnings would be -$0.4, but it ended up being -$0.41, beating the consensus by 2.40%. EBITDA was $8.03 million for the quarter. At the end of Teladoc Health Inc.’s most recent quarter ended June 29, its liabilities totaled 2.02 billion, while its total debt was $1.59 billion. Equity owned by shareholders amounts to $164.95 million.
Technical Picture
Here’s a quick look at Teladoc Health Inc.’s (TDOC) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 29.80%, suggesting the stock is oversold, with a 27.63% historical volatility rate.
The stochastic %K and %D were 12.21% and 8.80% respectively, while the average true range (ATR) was 0.94. Based on the 14-day stochastic reading of 18.57%, the RSI (14) reading is 36.21%. On the 9-day MACD Oscillator, the stock is at -0.67, and the 14-day reading is at -1.18.
Analyst Ratings
In its analyst report released on April 12, 2023, Stephens began covering Teladoc Health Inc. (NYSE: TDOC). The stock was rated as an Equal-weight by the brokerage firm. Analysts have assigned Teladoc Health Inc. (TDOC) an Hold rating. TDOC is a stock that is recommended for selling by 0 brokerage firms, while 23 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 5 others recommend it as a buy.
What is TDOC’s price target for the next 12 months?
The current consensus forecast for the stock is between $25.00 and $40.00, with a median target price of $29.00. In analyzing these forecasts, the average price target given by analysts for Teladoc Health Inc. (TDOC) is $29.73.
